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We thank Macaya et al1 for their interest in the MEMENTO-FFR 
study because it provides us with an additional opportunity to 
explain better the conclusions and implications for clinical prac-
tice of our study2. First of all, Macaya et al raised some con-
cern on the design of the study and in particular the fact that 
FFR was considered the standard reference. In this regard, the 
design of the MEMENTO-FFR is not different from a number of 
other studies, namely on the ability of iFR to predict FFR3,4. We 
agree with their opinion that FFR is not infallible; nevertheless, 
we think that everyone would also acknowledge that, at present, 
FFR is the most validated invasive tool for diagnosing a func-
tionally significant coronary artery stenosis in the catheterisation 
laboratory. Accordingly, in the current ESC guidelines for coro-
nary revascularisation, FFR has received a class IA recommen-
dation to assess the functional significance of a coronary stenosis 
when evidence of ischaemia is lacking5. Moreover, while in the 
early stages FFR was validated in comparison to several non-
invasive techniques6, now it has become the reference standard 
against which non-invasive tests are compared7. All these con-
siderations, in addition to the prognostic value and the ability to 
allocate the appropriate treatment correctly8, explain why FFR 
is now perceived by the general (including non-interventional) 
cardiology community as a cornerstone in the diagnosis of coro-
nary artery disease. Consequently, although we cannot dismiss 
the possibility that, in the (near) future, other indices (including 
cFFR) can achieve comparable efficiency, it is quite surprising 
that FFR is so strongly questioned by these very renowned inter-
ventional cardiologists.
A second potential concern, raised by the readers, is related to 
the similarity of the measured indices (Pd/Pa and, more impor-
tantly, cFFR) with FFR. In our opinion, the evidence that cFFR 
is very similar to FFR is not a weakness but rather a strength of 
cFFR. In the annoying battle to find an accurate and simple sur-
rogate for FFR, we have to bear in mind the starting point. This 
was the need to simplify and speed up the procedure in order to 
expand the use of functional evaluation of coronary stenosis in 
the real world, especially for those who, for financial, logistic or 
other reasons, cannot (or do not want to) use adenosine. For this 
purpose, given its accuracy and similarity to conventional “aden-
osine-based” FFR, cFFR is, in our opinion, a valuable and cost-
effective option. In addition, iFR, which, in the opinion of Macaya 
et al, is “mechanistically different from FFR, Pd/Pa and cFFR”, 
was originally proposed by Sen et al to circumvent the use of 
adenosine, hypothesising that during the cardiac cycle “there is 
a time when resistance is naturally minimised at rest” and conse-
quently that no vasodilator would be needed9. Unfortunately, this 
is not the case, as iFR during administration of adenosine is signi-
ficantly reduced, showing that resistance can be lowered further 
also during the so-called “wave-free period”10,11. Basically, as we 
clearly state in the MEMENTO-FFR paper, cFFR is a simple way 
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of inducing a somewhat lower degree of hyperaemia that could be 
enough for disclosing “significant” lesions in an important propor-
tion of cases, thus circumventing the use of adenosine.
While we know from CONTRAST and MEMENTO-FFR that 
cFFR performs better than resting indices in predicting FFR2,11, 
at this point we cannot answer the question which index (FFR, 
iFR, cFFR or whatever) could perform better in a study that 
would use another independent reference standard or other clini-
cal endpoints. This is an interesting point that still needs to be 
adequately demonstrated. Concerning iFR, we look forward to 
the upcoming results of very important clinical trials and, hope-
fully, to seeing replicated the vast amount of clinical evidence 
accumulated by FFR. In the meantime, we think that, despite the 
fact that the comparison of cFFR and iFR (which we do not test 
in our study at all) could be viewed like “comparing apples and 
pears”, this is what everyone does in everyday life in the cathlab. 
We bet that a hungry operator, coming out from a complex pro-
cedure, will choose from the fruit basket a fresh Red Delicious 
apple, very similar to his favourite Golden Delicious, instead of 
an anonymous rotten pear!
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